61 results
6-K
EX-99.5
REPCF
Replicel Life Sciences Inc.
18 Aug 21
Current report (foreign)
12:20pm
and professional recruitment services that meet clients’ needs. ACCERISE set up a joint venture with Hangzhou Tigermed Consulting Co., Ltd. in 2020 and are also
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
of our RCS-01 clinical trial. Approval from the PEI will enable us to immediately begin the recruitment phase of our trial. With the initiation
6-K
REPCF
Replicel Life Sciences Inc.
12 Sep 11
Current report (foreign)
12:00am
. To date, no serious adverse events have been reported post-injection. Please note that recruitment of subjects was closed at nineteen (rather than
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
29 May 14
Current report (foreign)
12:00am
or extrinsically via recruitment of collagen-producing cells from the surrounding area. Naturally healed tendon does not return to the same physiological state … recruitment; and inability to monitor patients adequately during or after treatment. In addition, we or regulatory officials may suspend our clinical trials
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
18 Mar 14
Current report (foreign)
12:00am
tendon occur. Once a tendon is injured, healing can occur intrinsically via tenocyte activation within the injured site or extrinsically via recruitment … of effectiveness during clinical trials; slower than expected rates of patient recruitment; and inability to monitor patients adequately during or after
6-K
EX-99.2
mda57dxy 462kga0b
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
lnzlaq y316l
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
hhte3lk
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
bdgj6yf5s83940rn
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.2
hho609i
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
r1f2uvsrob64hh6lbe7b
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
6-K
EX-99.2
tmhfqb o9c9w2d77
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
6aa3lettpvu5vi
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
4uow0sg0wcn1g2
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
mg35t1o
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
6-K
EX-99.2
luzqfi6n
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
vli3cgm 9icw3vo0
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.2
pr0 96zak8fkd715
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.3
szot2 kyf6z8m2
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
bp2n vo7dgrlf
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm